iCellate announces a new clinical collaboration with MD, PhD Peter Cashin at Akademiska Hospital in Uppsala, who will evaluate the clinical relevance of measuring levels of CTCs and to test their genetic properties pre, during and post HIPEC (hypothermal intraperitoneal chemotherapy) treatment in patients with peritoneal carcinomatosis (PC) from colorectal cancer.